News

Girls Cancer In Remission After Undergoing New Therapy In Bergen

The first two patients have successfully completed a new pediatric oncology immunotherapy program offered at the Children’s Cancer Institute at the Joseph M. Sanzari Children’s Hospital. The children’s hospital is the only site in New Jersey, and one of only 31 in the nation, offering the Novartis Pharmaceutical CAR-T Cell therapy. Alfred P. Gillio, M.D., director of the Children’s Cancer Institute, says the CAR-T Cell therapy, Kymriah, was approved by the FDA to treat children and young adults who have a challenging form of acute lymphoblastic leukemia (ALL.) (Note: this article was also featured on ParaumusPost.com and The Record Health Quarterly.)

READ FULL ARTICLE ON RAMAPO.DAILYVOICE.COM